Pfizer Finally Wins English Funding For Sickle Cell Drug Oxbryta After Bumpy Ride

3d rendered medical illustration of a sickle cell
Oxbryta will be funded immediately via England’s Innovative Medicines Fund. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Market Access

More from Pink Sheet